Results 161 to 170 of about 101,499 (309)

Loncastuximab Tesirine in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma: Evidence and Practical Guidance From Italian Clinical Experience

European Journal of Haematology, EarlyView.
ABSTRACT Patients with relapsed/refractory (R/R) diffuse large B‐cell lymphoma (DLBCL) who progress to the third‐line setting face a lack of standardized treatment, despite the presence of multiple available therapies. In this context, antibody–drug conjugates represent a relatively new class of anticancer agents; among them, loncastuximab tesirine is ...
Francesca Bonello, Andrea Aroldi, Alessia Castellino, Lara Mannelli, Elia Boccellato, Serena Rosati, Luisa Verga, Umberto Vitolo   +7 more
wiley   +1 more source

Real-life Use of Bexarotene for T-cell Cutaneous Lymphoma Management: Efficacy and Tolerance with Low Doses. [PDF]

Acta Derm Venereol, 2022
Rouanet J, Joulie I, Lambert C, D'Incan M.   +3 more
europepmc   +1 more source

Primary cardiac T‐cell rich large B‐cell lymphoma causing aortic stenosis with metastasis in a Warmblood

Equine Veterinary Education, EarlyView.
Summary An 18‐year‐old Warmblood mare was presented to the Royal Veterinary College Equine Referral Hospital for investigation of progressive periocular and facial swelling, weight loss and tachycardia. Physical examination additionally identified bilateral pansystolic (grade 5/6 basilar left‐sided, 2/6 right‐sided), cardiac murmurs, submandibular ...
S. E. Talbot, F. Z. X. Lean, H. M. Martineau, B. Dunkel, J. Reed   +4 more
wiley   +1 more source

Multifocal Indolent CD8+ Cutaneous T-Cell Lymphoma: A Novel Clinicopathologic Entity with Atypical Presentation

EJC Skin Cancer
K. Grafanaki, E. Stefani, K. Lambadaki, V. Pappa, L. Marinos, E. Papadavid   +5 more
doaj   +1 more source

Clinical Warburg Effect in a primary cutaneous lymphoma. [PDF]

Clin Hematol Int
Martins F, Fontinha G, Magalhães J, Cardoso JC, Calvão J.   +4 more
europepmc   +1 more source

Cutaneous Lymphoma

Dermatologic Clinics, 2015
openaire   +2 more sources

Targeting the microbiota‐miRNA‐protease axis: A new therapeutic avenue in melanoma

The FEBS Journal, EarlyView.
Modulation of extracellular matrix (ECM) turnover is central to melanoma progression and metastasis, driven largely by ECM proteases. This review highlights the epigenetic regulation of ECM proteases by microRNAs and their roles in melanoma growth, invasion, and immune modulation.
Elias N. Katsoulieris, Paraskevi Ioannou, Nikolaos A. Afratis   +2 more
wiley   +1 more source

Association of Secondary Primary Malignancies in Cutaneous Lymphoma: A Narrative Review. [PDF]

Diagnostics (Basel)
Hung YH, Hsiao PF.
europepmc   +1 more source

Tongue and teeth hyperpigmentation in etoposide, prednisolone, vincristine, and cyclophosphamide regimen in the treatment of cutaneous lymphoma.

Indian J Pharmacol, 2023
Morabad SS, Khan ZU, Gad R, Kallur N, Madhabhavi IV, Shalavadi MH, Mangannavar CV.   +6 more
europepmc   +1 more source

Evaluation of the International Society for Cutaneous Lymphoma Algorithm for the Diagnosis of Early Mycosis Fungoides. [PDF]

Cells, 2021
Ryu HJ, Kim SI, Jang HO, Kim SH, Oh SH, Park S, Kim SK.   +6 more
europepmc   +1 more source